Memantine for the treatment of dementia.
BACKGROUND: The use of cholinesterase inhibitors to correct the cholinergic deficit in patients with mild to moderate Alzheimer's disease (AD) is well established. However, the treatment is only effective in about half of the patients for whom it is prescribed. Vascular dementia may respond, at...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2003
|